Chromadex Corp (NASDAQ:CDXC) shares rose 7% on Tuesday . The company traded as high as $5.77 and last traded at $5.68. Approximately 586,900 shares changed hands during mid-day trading, an increase of 101% from the average daily volume of 291,862 shares. The stock had previously closed at $5.31.
CDXC has been the topic of a number of recent research reports. HC Wainwright set a $5.00 price objective on shares of Chromadex Corp and gave the company a “buy” rating in a research note on Friday, August 11th. Ladenburg Thalmann Financial Services started coverage on shares of Chromadex Corp in a report on Monday, September 25th. They issued a “buy” rating and a $7.00 target price for the company. ValuEngine upgraded shares of Chromadex Corp from a “sell” rating to a “hold” rating in a report on Friday, September 8th. Finally, Zacks Investment Research downgraded shares of Chromadex Corp from a “hold” rating to a “sell” rating in a report on Monday, July 17th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. Chromadex Corp presently has a consensus rating of “Hold” and an average price target of $6.33.
In other news, major shareholder Step Holdings Ltd Pioneer bought 786,167 shares of the stock in a transaction dated Friday, August 18th. The stock was bought at an average price of $2.60 per share, for a total transaction of $2,044,034.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Granite Investment Partners LLC increased its holdings in Chromadex Corp by 5.7% during the third quarter. Granite Investment Partners LLC now owns 250,276 shares of the company’s stock worth $1,076,000 after buying an additional 13,599 shares during the last quarter. Thompson Davis & CO. Inc. purchased a new stake in Chromadex Corp during the third quarter worth about $128,000. Bank of Montreal Can purchased a new stake in Chromadex Corp during the second quarter worth about $168,000. LMR Partners LLP purchased a new stake in Chromadex Corp during the second quarter worth about $347,000. Finally, North Star Investment Management Corp. increased its holdings in Chromadex Corp by 78.9% during the second quarter. North Star Investment Management Corp. now owns 265,334 shares of the company’s stock worth $1,014,000 after buying an additional 117,000 shares during the last quarter.
COPYRIGHT VIOLATION NOTICE: “Chromadex Corp (CDXC) Stock Price Up 7%” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.chaffeybreeze.com/2017/11/14/chromadex-corp-cdxc-stock-price-up-7.html.
Chromadex Corp Company Profile
Chromadex Corporation and its subsidiaries ChromaDex, Inc, ChromaDex Analytics, Inc and Spherix Consulting, Inc provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets.
Receive News & Ratings for Chromadex Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chromadex Corp and related companies with MarketBeat.com's FREE daily email newsletter.